期刊文献+

甲磺酸加替沙星片在健康志愿者体内的药动学 被引量:1

Pharmacokinetics of gatifloxacin mesylate tablets in healthy volunteers
下载PDF
导出
摘要 目的 :研究健康志愿者口服甲磺酸加替沙星片后的药动学特征 ,为临床安全、合理用药提供参考依据。方法 :18名健康男性单剂量口服甲磺酸加替沙星片 4 0 0mg ,以高效液相色谱法测定服药后 2 4h内的血药浓度 ,计算其药动学参数。结果 :甲磺酸加替沙星片在健康人体内的处置符合一级吸收的一室代谢模型 ,主要药动学参数Tmax,Cmax,T12 β,AUC( 0 2 4 ) 分别为 :(1.5±s 0 .4 )h ,(3.4± 1.0 )mg·L- 1,(6 .6± 1.0 )h ,(33± 10 )mg·h·L- 1。结论 :甲磺酸加替沙星在人体内的药动学特征与文献报道的盐酸加替沙星相似 ,口服吸收快 ,生物利用度高、体内平均滞留时间长 ,且存在个体差异。 AIM: To study the pharmocokinetics characteristics of gatifloxacin mesylate tablets in healthy volunteers in order to providing the verification of clinical safety and reasonable application of them. METHODS: Eighteen male subjects received a single oral dose of 400 mg of gatifloxacin mesylate. The plasma concentration of gatifloxacin mesylate was determined by HPLC method. RESULTS: The main pharmacokinetics parameters of gatifloxacin mesylate were as follows: T_ max, C_ max, T__ 12β, AUC_ (0-24) were (1.5±s 0.4) h, (3.4±1.0) mg·L -1,(6.6±1.0) h, (33±10) mg·h·L -1, respectively. CONCLUSION: The pharmacokinetics of gatifloxacin mesylate tablets are similar to those of gatifloxacin hydrochloride. It has advantage of quick absorption, high bioavailability and long mean retention time and inter-individual variability.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2004年第9期586-588,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 喹诺酮类 药动学 色谱法 高压液相 加替沙星 quinolones pharmacokinetics chromatography, high pressure liquid gatifloxacin
  • 相关文献

参考文献13

  • 1FUNG-TOMC J, MINASSIAN B, KOLEK B, et al. In vitro anti bacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatiflox acin[J]. J Antimicrob Chemother,2000,45(4):437-446.
  • 2TSURUMAKI Y, MANDA H, TAKEI M, et al. In vitro antimicrobial activity of gatifloxacin against 873 clinical isolates from respriration tract, urinary tract and surgical infections during 1997-1998 in Japan[J]. J Antimic rob Chemother,2000,45(5):685-689.
  • 3HAYWARD CL, ERWIN ME,BARRETT MS, et al. Comparative antimicrobia l activity of gatifloxacin tested against campylobacter jejuni including fluoroq uinolone resistant clinical isolates[J]. Diagn Microbiol Infect Dis, 1999,34( 2):99-102.
  • 4PERR CM, BARMAN-BALFOUR JA, LAMB HM. Gatifloxacin[J]. Drug,1999, 58(4):683-696.
  • 5LACRETA FP, KAUL S, KOLLIA GD, et al. Interchangeability of 400 mg intravenous and oral gatifloxacin in healthy adults[J]. Pharmacotherapy, 20 00,20(6 Pt 2):59S-66S.
  • 6EDLUND C, NORD CE. Ecological effect of gatifloxacin on the normal human intestinal microflora[J]. J Chemother,1999,11(1):50-53.
  • 7LOBER S, ZIEGE S, RAU M, et al. Pharmocokinetics of gatifloxacin and interaction with antacid containing aluminum and magnesium[J]. Antimicrob Agents Chemotherapy,1999,43(5):1067-1071.
  • 8MIGNOT A, GUILLAUME M, GOHLER K, et al. Oral bioavailabili t y of gatifloxacin in healthy volunteers under fasting and fed conditions[J]. C hemotherapy,2002,48(3):111-115.
  • 9LUBASCH A, KELLER I, BORNER K, et al. Comparative pharmacoketics of c i profloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxif loxacin after single oral administration in healthy volunteers[J]. Antimicrobi al Agents Chemotherapy,
  • 10-[10] See above

二级参考文献7

  • 1Lubasch A, Keller I, Borner K,et al. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers.J Anthmicrob Agents Chemother,2000,44(10) :2600
  • 2Naber CK, Steghafner M, Kingig-Schippers M, et al. Concentrations of gatifloxacin mesylate in plasma and urine and penetrition into prostatic and seminal fluid,ejaculate,and sperm cells after single oral administrations of 400 milligrams to volunteers. J Anthmicrob Agents Chemother,2001,45 (1) :293
  • 3Nakashima M, Uematsu T, Kosuge K,et al. Single - and multiple -dose pharmacokinetics of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone, in humans. J Antimicrob Agents Chemother, 1995, 39(12) :2635
  • 4Stahlberg H J, Gohler K, Guillane M,et al. Effects of gatifloxacin mesylate ( GTFX ) on the pharmacokinetics of theophyline in heathly young volunteers [ abstract]. J Antimicrob Agents Chemther, 1999,44(suppl A) :136
  • 5Perry CM, Balfour JAB, Lamb HM. Gatifloxacin. Drugs, 1999, 58(4) :683
  • 6Hosaka M,Yasue T,Fukuda H,et al. In vitro and in vivo antibacterial activities of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone. J Antimicrob Agents Chemother, 1992,36 ( l0 ) :2108
  • 7孙涛,宋坤改,林赴田.盐酸加替沙星的药代动力学研究[J].中国新药杂志,2000,9(11):758-761. 被引量:35

共引文献28

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部